Clinical Trials Directory

Trials / Completed

CompletedNCT04888117

Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy

COMPlex Cholecystectomy Trial (COMPaCT): A Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy

Status
Completed
Phase
Study type
Observational
Enrollment
186 (actual)
Sponsor
Intuitive Surgical · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The study aims to evaluate the short-term clinical outcomes after complex robotic-assisted and laparoscopic cholecystectomies.

Detailed description

This is a multi-center cohort study, evaluating short-term clinical outcomes after complex robotic-assisted and laparoscopic cholecystectomies. The primary outcomes include the rate of conversion to open, rate of intra-operative adverse events, the rate of post-operative adverse events relating to the cholecystectomy within 30 days, and re-admissions and re-operations relating to the cholecystectomy within 30 days. In addition, operative time, the rate of use of intra-operative imaging, the hospital length of stay, and pain and QOL scores will be collected as secondary outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic cholecystectomyWith the patient under general anesthesia, several small incisions are made in the abdomen. Ports are placed, the abdomen is insufflated, and laparoscopic instruments as well as a laparoscope are inserted to complete the cholecystectomy according to the surgeon's standard practice.
PROCEDURERobotic-assisted cholecystectomyWith the patient under general anesthesia, several small incisions are made in the abdomen. Ports are placed, the abdomen is insufflated, and the da Vinci Robotic Surgical System (Intuitive) is docked to the patient and used to complete the cholecystectomy according to the surgeon's standard of care.

Timeline

Start date
2021-06-05
Primary completion
2025-01-27
Completion
2025-01-27
First posted
2021-05-17
Last updated
2025-05-31

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04888117. Inclusion in this directory is not an endorsement.